-+ 0.00%
-+ 0.00%
-+ 0.00%

Acumen Pharmaceuticals Unveils Enhanced Brain Delivery Technology for Alzheimer’s Antibody in Phase 2 Trial

Reuters·12/02/2025 13:00:42

Please log in to view news